NCT04542811

Brief Summary

The investigators aimed to investigate the effect of acupuncture treatment on attack frequency, pain intensity, and disability in migraine without aura patients who receive prophylaxis treatment.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
84

participants targeted

Target at P50-P75 for not_applicable

Timeline
Completed

Started Mar 2018

Shorter than P25 for not_applicable

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

March 1, 2018

Completed
6 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

August 31, 2018

Completed
1 month until next milestone

Study Completion

Last participant's last visit for all outcomes

September 30, 2018

Completed
1.9 years until next milestone

First Submitted

Initial submission to the registry

September 2, 2020

Completed
7 days until next milestone

First Posted

Study publicly available on registry

September 9, 2020

Completed
Last Updated

September 16, 2020

Status Verified

September 1, 2020

Enrollment Period

6 months

First QC Date

September 2, 2020

Last Update Submit

September 11, 2020

Conditions

Keywords

migraineacupunctureMIDAS

Outcome Measures

Primary Outcomes (3)

  • Monthly attack frequency

    The participants will document the each migraine attack days in a month by pain free intervals of at least 48 hours.

    3 months

  • Duration of attacks

    Duration of the each migraine attack as hour

    3 months

  • Pain severity

    Pain severity during migraine attacks will be measured via visual analog scale (VAS). While 0 indicates no pain, 10 indicates the most severe pain imaginable.

    3 months

Secondary Outcomes (1)

  • Disability

    3 months

Study Arms (2)

Intervention group

EXPERIMENTAL

Intervention group will take 12 sessions of acupuncture addition to their prophylaxis treatment. Acupuncture points will be bilateral LI-4, LI-11, ST-8, ST-44, SP-6, GB-1, GB-14, GB-20, LR-3, and GV-14, GV-20. Sterile and single-use stainless steel acupuncture needles measuring 0.25x25 mm will be inserted to a depth of 10 mm and be retained for 30 minute without any further stimulation. Acupuncture will be performed by an acupuncturist with an acupuncture practitioner licence from the Turkish Ministry of Health. Adverse events will be monitored for all acupuncture sessions.

Other: Acupuncture

Control Group

NO INTERVENTION

Control group will take only their migraine prophylaxis treatment. Participants will followed-up 3 months.

Interventions

Acupuncture is a complementary therapy modality which is used by needle inserted the specific points on the body.

Intervention group

Eligibility Criteria

Age15 Years - 55 Years
Sexall
Healthy VolunteersNo
Age GroupsChild (0-17), Adult (18-64)

You may qualify if:

  • Being diagnosed with migraine according to IHS (International Headache Association)
  • Receiving migraine prophylaxis treatment
  • Having more than four attacks per month/more than one attack per week
  • Not having received acupuncture treatment before.

You may not qualify if:

  • Being diagnosed with migraine with aura/secondary headache
  • Having received acupuncture treatment for any reason within the last year
  • Not giving consent for acupuncture treatment
  • Having a fear of needles.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Rabia Rukiye Akinci

Erzurum, 25040, Turkey (Türkiye)

Location

MeSH Terms

Conditions

Migraine without AuraMigraine Disorders

Interventions

Acupuncture Therapy

Condition Hierarchy (Ancestors)

Headache Disorders, PrimaryHeadache DisordersBrain DiseasesCentral Nervous System DiseasesNervous System Diseases

Intervention Hierarchy (Ancestors)

Complementary TherapiesTherapeutics

Study Officials

  • Yasemin Çayır

    Ataturk University

    STUDY DIRECTOR

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
NONE
Purpose
PREVENTION
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Assoc. Prof.

Study Record Dates

First Submitted

September 2, 2020

First Posted

September 9, 2020

Study Start

March 1, 2018

Primary Completion

August 31, 2018

Study Completion

September 30, 2018

Last Updated

September 16, 2020

Record last verified: 2020-09

Data Sharing

IPD Sharing
Will not share

Locations